Reduction of Blood Recirculation in Veno-Venous ECMO

Recruiting Observational Study
Extracorporeal Membrane Oxygenation Acute Respiratory Distress Syndrome
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
136 (estimated)
Sponsor
Charite University, Berlin, Germany · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Blood which recirculates through the circuit of a veno-venous Extracorporeal Membrane Oxygenation (V-V ECMO) does not contribute to the systemic oxygenation of a patient on V-V ECMO and is called the recirculation fraction (Rf). Theoretically, the optimization of ECMO blood flow is possible using Rf measurements. A prospective, observational study will be performed measuring the Rf of total ECMO …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Patients aged 18 years or older requiring veno-venous ECMO for treatment of refractory hypoxemia in ARDS.
Contacts

Steffen Weber-Carstens, Prof. Dr. med.

0049-30450651005

steffen.weber-carstens@charite.de

CONTACT

Martin Russ, Dr. med.

0049-30450651268

martin.russ@charite.de

CONTACT